OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← IMD management

Full background report

Michael Tomasz

Chief Legal Officer and Company Secretary

Career chronology

Education and qualifications

Reported education and professional training

At FY26 reporting · issuer reported · low materiality

The issuer reports NSW and England/Wales legal admissions, Curtin MBA, Murdoch LLB and UWA geology degree. These credentials and current membership status were not independently checked.

Attribution: Responsibility not applicable. Issuer biography; not independently verified.

Relevance: Shows reported training relevant to the role.

IMDEX FY26 annual report (Physical page 29, Michael Tomasz biography)

Litigation and enforcement

Patent dispute resolved

2022–2024 · issuer reported · medium materiality

IMDEX’s February 2024 half-year report recorded an unsuccessful challenge and appeal on a Globaltech patent and a separate claim in its subsidiary’s favour. The August 2024 release announced a settlement with Boart Longyear including A$10m to IMDEX and resolution of proceedings. These corporate matters do not establish individual misconduct.

Attribution: Role overlaps event; causation unproven. Chief legal officer during the litigation; neither source establishes personal fault or identifies his personal contribution.

Relevance: Relevant to legal and intellectual-property oversight.

Half-year FY24 report (Page 20, note 11); Resolution of IP dispute with Boart Longyear (Page 1)

Suitability for the current role

Relevant experience for current role

2021–present · analyst inference · medium materiality

Joined IMDEX in 2021 as legal leader and is company secretary; the issuer lists past roles at Rio Tinto, Baker Hughes and JLL. The fit to the present mandate is an analyst inference; the underlying chronology is mainly company-reported.

Attribution: Responsibility not applicable. A role-fit judgment, not an independently measured individual outcome.

Relevance: Relevant to the assigned leadership responsibilities.

IMDEX FY26 annual report (Physical page 29, Michael Tomasz biography); 2026 AGM presentation and trading update (Physical page 28, executive leadership)

Evidence gaps

  • Independent verification of education, credentials and professional memberships is incomplete.

  • Complete prior-employer dates, role-specific outcomes and primary regulator/court records were not established.

  • The targeted open-web search is not exhaustive and does not establish absence of adverse records.